The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_206933.3(USH2A):c.2081G>A (p.Cys694Tyr)

CA1396311

418533 (ClinVar)

Gene: USH2A
Condition: Usher syndrome
Inheritance Mode: Autosomal recessive inheritance
UUID: 25255e2d-61ae-4965-aa8b-19b4610689ce
Approved on: 2020-01-21
Published on: 2020-01-21

HGVS expressions

NM_206933.3:c.2081G>A
NM_206933.3(USH2A):c.2081G>A (p.Cys694Tyr)
NC_000001.11:g.216250989C>T
CM000663.2:g.216250989C>T
NC_000001.10:g.216424331C>T
CM000663.1:g.216424331C>T
NC_000001.9:g.214490954C>T
NG_009497.1:g.177408G>A
NG_009497.2:g.177460G>A
ENST00000307340.8:c.2081G>A
ENST00000674083.1:c.2081G>A
ENST00000307340.7:c.2081G>A
ENST00000366942.3:c.2081G>A
NM_007123.5:c.2081G>A
NM_206933.2:c.2081G>A
NM_007123.6:c.2081G>A
NM_206933.4:c.2081G>A
More

Likely Pathogenic

Met criteria codes 4
PP3 PP4 PM2 PM3

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The c.2081G>A (p.Cys694Tyr) variant in USH2A is present in 0.0003% (the lower threshold of the 95% CI of 2/113290) European alleles (gnomAD v2.1.1), which is low enough frequency to apply PM2 based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive Usher syndrome (PM2). This variant has been detected in at least 1 patient with Usher syndrome in whom a pathogenic or suspected-pathogenic variant was observed in trans (PM3; VCV000002351.6; PMID: 28041643). The patient displayed features of hearing loss and retinitis pigmentosa, which is highly specific for USH2A (PP4; PMID: 28041643). The REVEL computational prediction analysis tool produced a score of 0.92 (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for autosomal recessive & Usher syndrome based on the ACMG/AMP criteria applied as specified by the Hearing Loss Expert Panel (PM2, PM3, PP4, PP3).
Met criteria codes
PP3
REVEL .92 No predicted splicing impact Evolutionarily conserved
PM2
0.0017% (2/113290) European alleles in gnomAD v2.1.1 0.0023% (1/42036) African and (1/64576) European alleles in gnomAD v3
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.